Research across borders

Worldwide Study Finder

Where are peptides being studied? Explore registered human studies by product, phase, condition and location — from early development through Phase 4, alongside studies where phase does not apply.

Searchable results come from ClinicalTrials.gov and include international sites. For broader coverage, use the worldwide and regional registries below. No single registry captures every study.

Find studies Explore world registries Peptide directory

Find a study

Enter a peptide, product, condition or location. Try generic names, brand names and development codes separately. Results are registry search matches, not automatically verified links to a WPF peptide record.

Search terms are sent to ClinicalTrials.gov and appear in the page URL. Do not enter personal or medical identifying information. Registry records are served with up to a one-hour cache; registry updates themselves can lag real-world changes.

Registry search results

Matching records; showing 20 on this page, newest registry updates first. Search checked 2026-11-09 01:00 UTC. Counts are registry matches, not unique peptides or a worldwide total.

Phase 1 / Phase 2UnknownINTERVENTIONAL

Tranexamic Acid and Ethamsylate For Preventing PPH in Patient Undergoing LSCS at High Risk For PPH

ClinicalTrials.gov · NCT02604719 · Registry updated: 2015-11-30

Condition / research focus: Postpartum Hemorrhage
Sponsor: Ahmed Alanwar
Countries with listed sites: No country reported
Registry dates and results: Start: 2015-11. Completion: 2016-07 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Tranexamic Acid and Ethamsylate (drug) — also listed as: kapron and dycinon

Where the study takes place — 0 listed sites

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

The registry does not list facilities in this record. This does not mean the study has no sites.

Original record, eligibility, contacts and results →

Phase 4TerminatedINTERVENTIONAL

Oxytocin and Cognitive Behavioral Therapy in Drug Dependence

ClinicalTrials.gov · NCT00975416 · Registry updated: 2015-11-20

Condition / research focus: Drug Dependence
Sponsor: National Institute on Drug Abuse (NIDA)
Countries with listed sites: United States
Registry dates and results: Start: 2008-11. Completion: 2013-04 (may be estimated). Results are posted in this registry.

Products and interventions (3)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Cognitive Behavioral Therapy (behavioral)
Intranasal Oxytocin (drug)
Placebo (drug)

Where the study takes place — 1 listed sites

National Institute on Drug Abuse
Baltimore, Maryland, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 4UnknownINTERVENTIONAL

The Effect of Intravenous Oxytocin Infusion Using Different Diluents on Neonatal Bilirubin & Sodium Levels

ClinicalTrials.gov · NCT02602301 · Registry updated: 2015-11-11

Condition / research focus: Neonatal Hyperbilirubinemia
Sponsor: Kasr El Aini Hospital
Countries with listed sites: No country reported
Registry dates and results: Start: 2015-11. Completion: 2016-03 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Oxytocin (drug) — also listed as: syntocinon

Where the study takes place — 0 listed sites

The registry does not list facilities in this record. This does not mean the study has no sites.

Original record, eligibility, contacts and results →

Phase 2CompletedINTERVENTIONAL

Intranasal Oxytocin in the Treatment of Autism

ClinicalTrials.gov · NCT00490802 · Registry updated: 2015-10-23

Condition / research focus: Autism
Sponsor: Evdokia Anagnostou
Countries with listed sites: United States
Registry dates and results: Start: 2006-06. Completion: 2012-04 (may be estimated). Results are posted in this registry.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Oxytocin (drug) — also listed as: Syntocinon
Placebo (drug)

Where the study takes place — 1 listed sites

Mount Sinai School of Medicine
New York, New York, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 2CompletedINTERVENTIONAL

An Efficacy Study of Vagitocin in Postmenopausal Women With Symptoms of Vaginal Atrophy

ClinicalTrials.gov · NCT02497547 · Registry updated: 2015-10-21

Condition / research focus: Atrophy
Sponsor: PepTonic Medical AB
Countries with listed sites: Sweden
Registry dates and results: Start: 2014-10. Completion: 2015-07 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Oxytocin (drug) — also listed as: Vagitocin
Placebo (drug)

Where the study takes place — 5 listed sites

Hoftekliniken
Helsingborg, Sweden
Site recruitment: Not reported
Qvinnolivet Specialistläkarna Kungsbacka
Kungsbacka, Sweden
Site recruitment: Not reported
Kvinnoforskningsenheten, Karolinska Universitetssjukhuset, Huddinge
Stockholm, Sweden
Site recruitment: Not reported
Kvinnokliniken, Norrlands Universitetssjukhus
Umeå, Sweden
Site recruitment: Not reported
Kvinnokliniken, Akademiska sjukhuset
Uppsala, Sweden
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase not reported / not applicableCompletedOBSERVATIONAL

Oxytocin Levels in Typically Developing Boys

ClinicalTrials.gov · NCT02006381 · Registry updated: 2015-09-22

Condition / research focus: Healthy Boys
Sponsor: University of North Carolina, Chapel Hill
Countries with listed sites: United States
Registry dates and results: Start: 2013-12. Completion: 2015-04 (may be estimated). No results posted in this registry response.

Products and interventions (0)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Where the study takes place — 1 listed sites

University of North Carolina Chapel Hill
Chapel Hill, North Carolina, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 3UnknownINTERVENTIONAL

Hexakaprone Treatment for Post-Partum Hemorrhage Prophylactic

ClinicalTrials.gov · NCT02362945 · Registry updated: 2015-09-09

Condition / research focus: Post-Partum Hemorrhage
Sponsor: Yariv yogev
Countries with listed sites: No country reported
Registry dates and results: Start: 2015-10. Completion: 2017-01 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Intervention group: (drug) — also listed as: Hexakaprone-Transexamic acid and oxytocin

Where the study takes place — 0 listed sites

The registry does not list facilities in this record. This does not mean the study has no sites.

Original record, eligibility, contacts and results →

Phase 3UnknownINTERVENTIONAL

Management of the Third Stage of Labor

ClinicalTrials.gov · NCT02319707 · Registry updated: 2015-09-09

Condition / research focus: Postpartum Hemorrhage
Sponsor: Yariv yogev
Countries with listed sites: No country reported
Registry dates and results: Start: 2015-09. Completion: 2017-01 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Oxytocin (drug) — also listed as: Pitocin
Oxytocin in 100 ml NaCl 0.9% (drug)

Where the study takes place — 0 listed sites

The registry does not list facilities in this record. This does not mean the study has no sites.

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

Investigating the Effect of Pulsatile Administration of Oxytocin on the Desensitization of Human Myometrium In-vitro

ClinicalTrials.gov · NCT02338089 · Registry updated: 2015-09-04

Condition / research focus: Postpartum Hemorrhage
Sponsor: Samuel Lunenfeld Research Institute, Mount Sinai Hospital
Countries with listed sites: Canada
Registry dates and results: Start: 2015-01. Completion: 2015-06 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Oxytocin (drug) — also listed as: pitocin

Where the study takes place — 1 listed sites

Mount Sinai Hospital
Toronto, Ontario, Canada
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableUnknownINTERVENTIONAL

Effects of Intranasal Oxytocin and Vasopressin on Social Behavior and Decision Making

ClinicalTrials.gov · NCT02526914 · Registry updated: 2015-08-18

Condition / research focus: Healthy
Sponsor: David Mankuta
Countries with listed sites: Israel
Registry dates and results: Start: 2015-10. Completion: 2017-10 (may be estimated). No results posted in this registry response.

Products and interventions (3)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Intranasal Oxytocin (drug) — also listed as: syntocinon
Intranasal vasopressin (drug)
Intranasal placebo (drug)

Where the study takes place — 1 listed sites

Hadassah University Medical Organization
Jerusalem, Jerusalem, Israel
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase not reported / not applicableCompletedOBSERVATIONAL

Role of Oxytocin in Post-menopausal Osteoporosis: Evaluation on the Population of the OPUS Cohort

ClinicalTrials.gov · NCT01192893 · Registry updated: 2015-08-14

Condition / research focus: Osteoporosis
Sponsor: Centre Hospitalier Universitaire de Nice
Countries with listed sites: France
Registry dates and results: Start: 2011-07. Completion: 2013-10 (may be estimated). No results posted in this registry response.

Products and interventions (0)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Where the study takes place — 1 listed sites

Hôpital Archet 1
Nice, France
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

Labour Augmentation by Means of Oxytocin - Obstetric Outcome and Women's Experiences

ClinicalTrials.gov · NCT01263158 · Registry updated: 2015-08-11

Condition / research focus: Slow Labour Progress
Sponsor: Göteborg University
Countries with listed sites: Sweden
Registry dates and results: Start: 1998-10. Completion: 2003-12 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Expectancy of standard oxytocin treatment (other)

Where the study takes place — 1 listed sites

Institute of Health and Care Sciences, University of Gothenburg
Gothenburg, Sweden
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 4CompletedINTERVENTIONAL

Medical Management of Late Intrauterine Death.

ClinicalTrials.gov · NCT02488642 · Registry updated: 2015-07-24

Condition / research focus: Cervical Pregnancy; Maternal Care for Late Fetal Death
Sponsor: National Institute of Perinatology
Countries with listed sites: No country reported
Registry dates and results: Start: 2008-05. Completion: 2014-05 (may be estimated). No results posted in this registry response.

Products and interventions (3)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Isosorbide Dinitrate (drug) — also listed as: Isordil, Dilatrate-SR, Sorbitrate
Misoprostol (drug) — also listed as: Cytotec
Oxytocin (drug)

Where the study takes place — 0 listed sites

The registry does not list facilities in this record. This does not mean the study has no sites.

Original record, eligibility, contacts and results →

Early Phase 1CompletedINTERVENTIONAL

The Influence of Oxytocin on Pair-bonding and Emotion Regulation

ClinicalTrials.gov · NCT02501837 · Registry updated: 2015-07-17

Condition / research focus: Healthy
Sponsor: University Hospital, Bonn
Countries with listed sites: Germany
Registry dates and results: Start: 2014-07. Completion: 2015-06 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Syntocinon-Spray (drug)

Where the study takes place — 1 listed sites

Department of Psychiatry, University of Bonn
Bonn, Germany
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableUnknownINTERVENTIONAL

Postpartum Uterotonic Administration

ClinicalTrials.gov · NCT02495272 · Registry updated: 2015-07-13

Condition / research focus: Postpartum Bleeding
Sponsor: Bagcilar Training and Research Hospital
Countries with listed sites: Turkey (Türkiye)
Registry dates and results: Start: 2014-06. Completion: 2016-01 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Oxytocin (drug) — also listed as: PostuitrinFort Amp I.E.Ulagay

Where the study takes place — 1 listed sites

Kanuni Sultan Suleyman Teaching and Research Hospital
Istanbul, Turkey (Türkiye)
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Early Phase 1SuspendedINTERVENTIONAL

The Effect of Oxytocin on Face Perception

ClinicalTrials.gov · NCT02091817 · Registry updated: 2015-07-02

Condition / research focus: Healthy; Congenital Prosopagnosia
Sponsor: Soroka University Medical Center
Countries with listed sites: Israel
Registry dates and results: Start: 2013-11. Completion: 2017-12 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Oxytocin (drug) — also listed as: syntocinon
Placebo (drug)

Where the study takes place — 1 listed sites

Soroka medical center
Beersheba, Israel, Israel
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 3CompletedINTERVENTIONAL

Carbetocin Versus Oxytocin in the Prevention of Post Partum Haemorrhage (PPH) in Women Delivered Vaginally With at Least 2 Risk Factors for Atonic PPH: A Randomised Controlled Trial

ClinicalTrials.gov · NCT02304042 · Registry updated: 2015-07-02

Condition / research focus: Delivery
Sponsor: Cairo University
Countries with listed sites: Egypt
Registry dates and results: Start: 2014-11. Completion: 2015-07 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Carbetocin (drug)
Oxytocin (drug)

Where the study takes place — 2 listed sites

BeniSuef University hospitals
BeniSuef, Egypt
Site recruitment: Not reported
Cairo University Hospitals
Cairo, Egypt
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 3TerminatedINTERVENTIONAL

Accelerated Titration of Oxytocin for Nulliparous Patients With Labour Dystocia: ACTION Pilot Study

ClinicalTrials.gov · NCT01397630 · Registry updated: 2015-06-25

Condition / research focus: Labour Dystocia
Sponsor: Ottawa Hospital Research Institute
Countries with listed sites: Canada
Registry dates and results: Start: 2012-04. Completion: 2013-11 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Oxytocin (drug) — also listed as: Pitocin, Syntocinon, Uteracon

Where the study takes place — 2 listed sites

The Ottawa Hospital Research Institute
Ottawa, Ontario, Canada
Site recruitment: Not reported
Sainte-Justine Hospital
Montreal, Quebec, Canada
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 1CompletedINTERVENTIONAL

Oxytocin Treatment of Social Cognitive and Functional Deficits in Schizophrenia

ClinicalTrials.gov · NCT01394471 · Registry updated: 2015-06-11

Condition / research focus: Schizophrenia; Schizoaffective Disorder
Sponsor: University of North Carolina, Chapel Hill
Countries with listed sites: United States
Registry dates and results: Start: 2011-07. Completion: 2015-01 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Intranasal Oxytocin Spray (drug) — also listed as: Syntocinon spray

Where the study takes place — 1 listed sites

University of North Carolina at Chapel Hill
Chapel Hill, North Carolina, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 4UnknownINTERVENTIONAL

The Comparison of Oxytocin Induced Labor and Cook Balloon Induced Labor

ClinicalTrials.gov · NCT02202083 · Registry updated: 2015-06-08

Condition / research focus: Labor; Forced or Induced, Affecting Fetus or Newborn
Sponsor: West China Second University Hospital
Countries with listed sites: China
Registry dates and results: Start: 2014-06. Completion: 2015-09 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Cook Balloon (other)

Where the study takes place — 1 listed sites

West China Second Hospital
Chengdu, Sichuan, China
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Explore the world’s study registries

These links open external registries; their records are not merged into the results above. WHO ICTRP provides a broader search across contributing registries. Search the same generic name, aliases and development codes in relevant regions. One multinational study may appear in more than one registry, so compare registration identifiers before counting it twice.

Worldwide

Africa

Pan African Clinical Trial Registry ↗

Americas

Asia

Middle East

Europe

Oceania

Australia / New Zealand — ANZCTR ↗

Registry directory checked October 5, 2026 against the WHO registry network. This is a starting point, not complete coverage of every country or continent. Record availability, language and update schedules vary by registry.

Worldwide Study Finder

Loading registry information…

Worldwide Study Finder

Where are peptides being studied? Explore registered human studies by product, phase, condition and location — from early development through Phase 4, alongside studies where phase does not apply.

Searchable results come from ClinicalTrials.gov and include international sites. For broader coverage, use the worldwide and regional registries below. No single registry captures every study.

Find a study

Registry search results

Matching records; showing 20 on this page, newest registry updates first. Search checked 2026-11-09 01:00 UTC. Counts are registry matches, not unique peptides or a worldwide total.

Phase 1 / Phase 2UnknownINTERVENTIONAL

Tranexamic Acid and Ethamsylate For Preventing PPH in Patient Undergoing LSCS at High Risk For PPH

ClinicalTrials.gov · NCT02604719 · Registry updated: 2015-11-30

Condition / research focus: Postpartum Hemorrhage
Sponsor: Ahmed Alanwar
Countries with listed sites: No country reported
Registry dates and results: Start: 2015-11. Completion: 2016-07 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Tranexamic Acid and Ethamsylate (drug) — also listed as: kapron and dycinon

Where the study takes place — 0 listed sites

The registry does not list facilities in this record. This does not mean the study has no sites.

Original record, eligibility, contacts and results →

Phase 4TerminatedINTERVENTIONAL

Oxytocin and Cognitive Behavioral Therapy in Drug Dependence

ClinicalTrials.gov · NCT00975416 · Registry updated: 2015-11-20

Condition / research focus: Drug Dependence
Sponsor: National Institute on Drug Abuse (NIDA)
Countries with listed sites: United States
Registry dates and results: Start: 2008-11. Completion: 2013-04 (may be estimated). Results are posted in this registry.

Products and interventions (3)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Cognitive Behavioral Therapy (behavioral)
Intranasal Oxytocin (drug)
Placebo (drug)

Where the study takes place — 1 listed sites

National Institute on Drug Abuse
Baltimore, Maryland, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 4UnknownINTERVENTIONAL

The Effect of Intravenous Oxytocin Infusion Using Different Diluents on Neonatal Bilirubin & Sodium Levels

ClinicalTrials.gov · NCT02602301 · Registry updated: 2015-11-11

Condition / research focus: Neonatal Hyperbilirubinemia
Sponsor: Kasr El Aini Hospital
Countries with listed sites: No country reported
Registry dates and results: Start: 2015-11. Completion: 2016-03 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Oxytocin (drug) — also listed as: syntocinon

Where the study takes place — 0 listed sites

The registry does not list facilities in this record. This does not mean the study has no sites.

Original record, eligibility, contacts and results →

Phase 2CompletedINTERVENTIONAL

Intranasal Oxytocin in the Treatment of Autism

ClinicalTrials.gov · NCT00490802 · Registry updated: 2015-10-23

Condition / research focus: Autism
Sponsor: Evdokia Anagnostou
Countries with listed sites: United States
Registry dates and results: Start: 2006-06. Completion: 2012-04 (may be estimated). Results are posted in this registry.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Oxytocin (drug) — also listed as: Syntocinon
Placebo (drug)

Where the study takes place — 1 listed sites

Mount Sinai School of Medicine
New York, New York, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 2CompletedINTERVENTIONAL

An Efficacy Study of Vagitocin in Postmenopausal Women With Symptoms of Vaginal Atrophy

ClinicalTrials.gov · NCT02497547 · Registry updated: 2015-10-21

Condition / research focus: Atrophy
Sponsor: PepTonic Medical AB
Countries with listed sites: Sweden
Registry dates and results: Start: 2014-10. Completion: 2015-07 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Oxytocin (drug) — also listed as: Vagitocin
Placebo (drug)

Where the study takes place — 5 listed sites

Hoftekliniken
Helsingborg, Sweden
Site recruitment: Not reported
Qvinnolivet Specialistläkarna Kungsbacka
Kungsbacka, Sweden
Site recruitment: Not reported
Kvinnoforskningsenheten, Karolinska Universitetssjukhuset, Huddinge
Stockholm, Sweden
Site recruitment: Not reported
Kvinnokliniken, Norrlands Universitetssjukhus
Umeå, Sweden
Site recruitment: Not reported
Kvinnokliniken, Akademiska sjukhuset
Uppsala, Sweden
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase not reported / not applicableCompletedOBSERVATIONAL

Oxytocin Levels in Typically Developing Boys

ClinicalTrials.gov · NCT02006381 · Registry updated: 2015-09-22

Condition / research focus: Healthy Boys
Sponsor: University of North Carolina, Chapel Hill
Countries with listed sites: United States
Registry dates and results: Start: 2013-12. Completion: 2015-04 (may be estimated). No results posted in this registry response.

Products and interventions (0)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Where the study takes place — 1 listed sites

University of North Carolina Chapel Hill
Chapel Hill, North Carolina, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 3UnknownINTERVENTIONAL

Hexakaprone Treatment for Post-Partum Hemorrhage Prophylactic

ClinicalTrials.gov · NCT02362945 · Registry updated: 2015-09-09

Condition / research focus: Post-Partum Hemorrhage
Sponsor: Yariv yogev
Countries with listed sites: No country reported
Registry dates and results: Start: 2015-10. Completion: 2017-01 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Intervention group: (drug) — also listed as: Hexakaprone-Transexamic acid and oxytocin

Where the study takes place — 0 listed sites

The registry does not list facilities in this record. This does not mean the study has no sites.

Original record, eligibility, contacts and results →

Phase 3UnknownINTERVENTIONAL

Management of the Third Stage of Labor

ClinicalTrials.gov · NCT02319707 · Registry updated: 2015-09-09

Condition / research focus: Postpartum Hemorrhage
Sponsor: Yariv yogev
Countries with listed sites: No country reported
Registry dates and results: Start: 2015-09. Completion: 2017-01 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Oxytocin (drug) — also listed as: Pitocin
Oxytocin in 100 ml NaCl 0.9% (drug)

Where the study takes place — 0 listed sites

The registry does not list facilities in this record. This does not mean the study has no sites.

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

Investigating the Effect of Pulsatile Administration of Oxytocin on the Desensitization of Human Myometrium In-vitro

ClinicalTrials.gov · NCT02338089 · Registry updated: 2015-09-04

Condition / research focus: Postpartum Hemorrhage
Sponsor: Samuel Lunenfeld Research Institute, Mount Sinai Hospital
Countries with listed sites: Canada
Registry dates and results: Start: 2015-01. Completion: 2015-06 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Oxytocin (drug) — also listed as: pitocin

Where the study takes place — 1 listed sites

Mount Sinai Hospital
Toronto, Ontario, Canada
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableUnknownINTERVENTIONAL

Effects of Intranasal Oxytocin and Vasopressin on Social Behavior and Decision Making

ClinicalTrials.gov · NCT02526914 · Registry updated: 2015-08-18

Condition / research focus: Healthy
Sponsor: David Mankuta
Countries with listed sites: Israel
Registry dates and results: Start: 2015-10. Completion: 2017-10 (may be estimated). No results posted in this registry response.

Products and interventions (3)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Intranasal Oxytocin (drug) — also listed as: syntocinon
Intranasal vasopressin (drug)
Intranasal placebo (drug)

Where the study takes place — 1 listed sites

Hadassah University Medical Organization
Jerusalem, Jerusalem, Israel
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase not reported / not applicableCompletedOBSERVATIONAL

Role of Oxytocin in Post-menopausal Osteoporosis: Evaluation on the Population of the OPUS Cohort

ClinicalTrials.gov · NCT01192893 · Registry updated: 2015-08-14

Condition / research focus: Osteoporosis
Sponsor: Centre Hospitalier Universitaire de Nice
Countries with listed sites: France
Registry dates and results: Start: 2011-07. Completion: 2013-10 (may be estimated). No results posted in this registry response.

Products and interventions (0)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Where the study takes place — 1 listed sites

Hôpital Archet 1
Nice, France
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

Labour Augmentation by Means of Oxytocin - Obstetric Outcome and Women's Experiences

ClinicalTrials.gov · NCT01263158 · Registry updated: 2015-08-11

Condition / research focus: Slow Labour Progress
Sponsor: Göteborg University
Countries with listed sites: Sweden
Registry dates and results: Start: 1998-10. Completion: 2003-12 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Expectancy of standard oxytocin treatment (other)

Where the study takes place — 1 listed sites

Institute of Health and Care Sciences, University of Gothenburg
Gothenburg, Sweden
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 4CompletedINTERVENTIONAL

Medical Management of Late Intrauterine Death.

ClinicalTrials.gov · NCT02488642 · Registry updated: 2015-07-24

Condition / research focus: Cervical Pregnancy; Maternal Care for Late Fetal Death
Sponsor: National Institute of Perinatology
Countries with listed sites: No country reported
Registry dates and results: Start: 2008-05. Completion: 2014-05 (may be estimated). No results posted in this registry response.

Products and interventions (3)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Isosorbide Dinitrate (drug) — also listed as: Isordil, Dilatrate-SR, Sorbitrate
Misoprostol (drug) — also listed as: Cytotec
Oxytocin (drug)

Where the study takes place — 0 listed sites

The registry does not list facilities in this record. This does not mean the study has no sites.

Original record, eligibility, contacts and results →

Early Phase 1CompletedINTERVENTIONAL

The Influence of Oxytocin on Pair-bonding and Emotion Regulation

ClinicalTrials.gov · NCT02501837 · Registry updated: 2015-07-17

Condition / research focus: Healthy
Sponsor: University Hospital, Bonn
Countries with listed sites: Germany
Registry dates and results: Start: 2014-07. Completion: 2015-06 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Syntocinon-Spray (drug)

Where the study takes place — 1 listed sites

Department of Psychiatry, University of Bonn
Bonn, Germany
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableUnknownINTERVENTIONAL

Postpartum Uterotonic Administration

ClinicalTrials.gov · NCT02495272 · Registry updated: 2015-07-13

Condition / research focus: Postpartum Bleeding
Sponsor: Bagcilar Training and Research Hospital
Countries with listed sites: Turkey (Türkiye)
Registry dates and results: Start: 2014-06. Completion: 2016-01 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Oxytocin (drug) — also listed as: PostuitrinFort Amp I.E.Ulagay

Where the study takes place — 1 listed sites

Kanuni Sultan Suleyman Teaching and Research Hospital
Istanbul, Turkey (Türkiye)
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Early Phase 1SuspendedINTERVENTIONAL

The Effect of Oxytocin on Face Perception

ClinicalTrials.gov · NCT02091817 · Registry updated: 2015-07-02

Condition / research focus: Healthy; Congenital Prosopagnosia
Sponsor: Soroka University Medical Center
Countries with listed sites: Israel
Registry dates and results: Start: 2013-11. Completion: 2017-12 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Oxytocin (drug) — also listed as: syntocinon
Placebo (drug)

Where the study takes place — 1 listed sites

Soroka medical center
Beersheba, Israel, Israel
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 3CompletedINTERVENTIONAL

Carbetocin Versus Oxytocin in the Prevention of Post Partum Haemorrhage (PPH) in Women Delivered Vaginally With at Least 2 Risk Factors for Atonic PPH: A Randomised Controlled Trial

ClinicalTrials.gov · NCT02304042 · Registry updated: 2015-07-02

Condition / research focus: Delivery
Sponsor: Cairo University
Countries with listed sites: Egypt
Registry dates and results: Start: 2014-11. Completion: 2015-07 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Carbetocin (drug)
Oxytocin (drug)

Where the study takes place — 2 listed sites

BeniSuef University hospitals
BeniSuef, Egypt
Site recruitment: Not reported
Cairo University Hospitals
Cairo, Egypt
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 3TerminatedINTERVENTIONAL

Accelerated Titration of Oxytocin for Nulliparous Patients With Labour Dystocia: ACTION Pilot Study

ClinicalTrials.gov · NCT01397630 · Registry updated: 2015-06-25

Condition / research focus: Labour Dystocia
Sponsor: Ottawa Hospital Research Institute
Countries with listed sites: Canada
Registry dates and results: Start: 2012-04. Completion: 2013-11 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Oxytocin (drug) — also listed as: Pitocin, Syntocinon, Uteracon

Where the study takes place — 2 listed sites

The Ottawa Hospital Research Institute
Ottawa, Ontario, Canada
Site recruitment: Not reported
Sainte-Justine Hospital
Montreal, Quebec, Canada
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 1CompletedINTERVENTIONAL

Oxytocin Treatment of Social Cognitive and Functional Deficits in Schizophrenia

ClinicalTrials.gov · NCT01394471 · Registry updated: 2015-06-11

Condition / research focus: Schizophrenia; Schizoaffective Disorder
Sponsor: University of North Carolina, Chapel Hill
Countries with listed sites: United States
Registry dates and results: Start: 2011-07. Completion: 2015-01 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Intranasal Oxytocin Spray (drug) — also listed as: Syntocinon spray

Where the study takes place — 1 listed sites

University of North Carolina at Chapel Hill
Chapel Hill, North Carolina, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 4UnknownINTERVENTIONAL

The Comparison of Oxytocin Induced Labor and Cook Balloon Induced Labor

ClinicalTrials.gov · NCT02202083 · Registry updated: 2015-06-08

Condition / research focus: Labor; Forced or Induced, Affecting Fetus or Newborn
Sponsor: West China Second University Hospital
Countries with listed sites: China
Registry dates and results: Start: 2014-06. Completion: 2015-09 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Cook Balloon (other)

Where the study takes place — 1 listed sites

West China Second Hospital
Chengdu, Sichuan, China
Site recruitment: Recruiting

Original record, eligibility, contacts and results →